NervGen Pharma Corp. (NGEN)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Oct 27, 16:00
1.48
0.00 (0.00%)
After-Hours: 19:53
NervGen Pharma Free Cash Flow : -18.43M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.43M |
| March 31, 2026 | -17.09M |
| December 31, 2025 | -13.98M |
| September 30, 2025 | -11.89M |
| June 30, 2025 | -12.23M |
| March 31, 2025 | -12.51M |
| December 31, 2024 | -12.04M |
| September 30, 2024 | -11.83M |
| June 30, 2024 | -8.677M |
| March 31, 2024 | -7.170M |
| December 31, 2023 | -8.297M |
| September 30, 2023 | -9.475M |
| June 30, 2023 | -11.94M |
| March 31, 2023 | -13.31M |
| December 31, 2022 | -13.11M |
| Date | Value |
|---|---|
| September 30, 2022 | -12.03M |
| June 30, 2022 | -10.02M |
| March 31, 2022 | -8.921M |
| December 31, 2021 | -6.596M |
| September 30, 2021 | -5.904M |
| June 30, 2021 | -5.314M |
| March 31, 2021 | -4.439M |
| December 31, 2020 | -4.843M |
| September 30, 2020 | -4.795M |
| June 30, 2020 | -5.510M |
| March 31, 2020 | -5.604M |
| December 31, 2019 | -6.132M |
| September 30, 2019 | -5.139M |
| June 30, 2019 | -3.807M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
| Appili Therapeutics, Inc. | -1.022M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.527M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.086M |
| Cash from Investing (Quarterly) | -0.0001M |
| Cash from Financing (Quarterly) | 56.43M |
| Free Cash Flow Per Share (Quarterly) | -0.0389 |
| Free Cash Flow to Equity (Quarterly) | -4.086M |
| Free Cash Flow to Firm (Quarterly) | -4.086M |
| Free Cash Flow Yield | -14.86% |